Shenzhen Tiantu Capital Co., Ltd.

1973

CNE100005MW3

Investment Management & Fund Operators

End-of-day quote Hong Kong S.E. Other stock markets 23:00:00 25/06/2024 BST			5-day change	1st Jan Change
3.26 ^CNY	0.00%		+2.84%	-50.38%

06-17	Leman Biotech Co., Ltd. announced that it has received funding from FUHO Capital Management Co., Ltd., XtalPi Inc., Henan Yunfan Electronic Technology Co., Ltd., Tian Tu Capital Co., Ltd. and other investors	CI
05-23	Tian Tu Capital Co., Ltd. Appoints Wang Shilin as an Independent Non-Executive Director and as the Chairman of the Remuneration Committee and A Member of the Nomination Committee	CI

Leman Biotech Co., Ltd. announced that it has received funding from Tian Tu Capital Co., Ltd. and other investors

October 09, 2023

Leman Biotech Co., Ltd. announced that it has received funding on October 10, 2023. The transaction included participation from new investor Tian Tu Capital Co., Ltd. and other investors.

Latest news about Shenzhen Tiantu Capital Co., Ltd.

Leman Biotech Co., Ltd. announced that it has received funding from FUHO Capital Management Co., Ltd., XtalPi Inc., Henan Yunfan Electronic Technology Co., Ltd., Tian Tu Capital Co., Ltd. and other investors	06-16	CI
Tian Tu Capital Co., Ltd. Appoints Wang Shilin as an Independent Non-Executive Director and as the Chairman of the Remuneration Committee and A Member of the Nomination Committee	05-23	CI
Tian Tu Capital Co., Ltd. Announces the Resignation of Liu Pingchun as Independent Non-Executive Director, the Chairman of the Remuneration Committee and Member of the Nomination Committee	04-30	CI
Hunan Chayue Cultural Industry Development Group Co Ltd announced that it has received CNY 1 million in funding from Tian Tu Capital Co., Ltd.	04-24	CI
Certain H Shares of Tian Tu Capital Co., Ltd. are subject to a Lock-Up Agreement Ending on 6-APR-2024.	04-05	CI
Ziyan Foods Ties Up With Equity Investor to Set Up 300 Million Yuan Food Industry Fund	04-05	MT
Tian Tu Capital Swings to Loss in 2023	04-01	MT
Tian Tu Capital Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Tian Tu Capital Co., Ltd. Decides Not to Declare Final Dividend for the Year Ended December 31, 2023	03-28	CI
Guangzhou Insight Technology Co., Ltd. announced that it has received funding from Tian Tu Capital Co., Ltd., Yael Capital, Forcefield Ventures and other investors	03-21	CI
Tian Tu Capital Flags Losses for 2023	03-11	MT
Tian Tu Capital Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2023	03-08	CI
Beijing's Embargo on Mainland IPOs Could Boost Listings on HKEX	11-24	MT
Tian Tu Capital Subsidiary to Invest in Recycling System Operator	11-21	MT
Chengdu Eventec Technology Co., Ltd. announced that it has received funding from Tian Tu Capital Co., Ltd., Cheetah Mobile Inc. and other investors.	29/10/23	CI
Leman Biotech Co., Ltd. announced that it has received funding from Tian Tu Capital Co., Ltd. and other investors	09/10/23	CI
Hopes for New Property Sector Measures Boost Hong Kong Stocks; Tian Tu Capital Drops 25% at Debut	06/10/23	MT
Tian Tu Capital Co., Ltd. has completed an IPO in the amount of HKD 1.126177 billion.	05/10/23	CI
Tian Tu Capital Raises HK$1 Billion in Hong Kong IPO, Prices Near Bottom of Range	05/10/23	MT
Tian Tu Capital Co., Ltd. has filed an IPO in the amount of HKD 1.975141 billion.	25/09/23	CI
Tian Tu Capital Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI

Chart Shenzhen Tiantu Capital Co., Ltd.

Duration

Period

More charts

Tian Tu Capital Co Ltd is a China-based company mainly engaged in private equity investment and fund management. The Company's main businesses include the provision of capital management services to institutional investors and high net worth individuals such as Chinese consumer brands and companies, and to invest through the Company's own funds and managed funds. The Company's investment mainly involves the consumption filed in the domestic market of China mainland. The Company mainly conducts its business in the domestic market.

Sector

Investment Management & Fund Operators

Calendar

28/06/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.033 CNY

Average target price

8.694 CNY

Spread / Average Target

+186.61%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
SHENZHEN TIANTU CAPITAL CO., LTD.	-50.38%	289M
BLACKROCK, INC.	-3.00%	117B
UBS GROUP AG	+0.46%	93.94B
APOLLO GLOBAL MANAGEMENT, INC.	+26.69%	67.18B
BROOKFIELD CORPORATION	+5.40%	63.41B
BANK OF NEW YORK MELLON CORPORATION (THE)	+12.72%	43.87B
AMERIPRISE FINANCIAL, INC.	+14.23%	43.1B
3I GROUP PLC	+26.10%	37.6B
T. ROWE PRICE GROUP INC.	+8.19%	26.02B
STATE STREET CORPORATION	-5.94%	21.95B

Other Investment Management & Fund Operators

Shenzhen Tiantu Capital Co., Ltd.

Equities

1973

CNE100005MW3

Investment Management & Fund Operators

Leman Biotech Co., Ltd. announced that it has received funding from Tian Tu Capital Co., Ltd. and other investors

Latest news about Shenzhen Tiantu Capital Co., Ltd.

Chart Shenzhen Tiantu Capital Co., Ltd.

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Investment Management & Fund Operators